Target intelligence / Profile preview

T Cell Antigen Recognition via Major Histocompatibility Complex Presentation (TCR-MHC Interaction)

Target
TCR-MHC Interaction
Molecular classification
Receptor-ligand interaction, Immune signaling pathway, MHC Class I, MHC Class II, T cell receptor complex, Co-stimulatory molecules
01

Overview

T cell antigen recognition via major histocompatibility complex (MHC) presentation is a fundamental process in adaptive immunity. T cells recognize antigens as short peptide fragments that are processed and displayed on the surface of cells bound to MHC molecules. This interaction is mediated by the T cell receptor (TCR), which specifically binds to the peptide-MHC complex, initiating a cascade of signaling events that lead to T cell activation. MHC molecules present peptides derived from intracellular (Class I) or extracellular (Class II) proteins. Co-receptors (CD4/CD8) and co-stimulatory molecules are also crucial for effective T cell activation. This process is vital for detecting pathogen-infected or abnormal self-cells while maintaining tolerance toward healthy tissue. Dysregulation can result in autoimmunity or immunodeficiency.

Other names
TCR signalingMHC-mediated antigen presentationT cell activationAntigen presentation pathway
02

Mechanism of action

Modulation of T cell activation, inhibition of co-stimulation, blockade of TCR signaling, or depletion of T cells.

03

Biological functions

Antigen recognitionT cell activationAdaptive immunityCytokine productionCytotoxicityT cell differentiationSignal transduction
04

Disease associations

AutoimmunityImmunodeficiencyCancerInfectionTransplant rejectionInflammation
05

Safety considerations

Opportunistic infections (due to immunosuppression)Autoimmunity (due to immune dysregulation)Cytokine release syndromeGraft-versus-host diseaseIncreased risk of certain cancers
06

Interacting drugs

Immunosuppressants (e.g., Cyclosporine, Tacrolimus)

4 more in the full profile.

07

Biomarkers

MHC allele expressionTCR repertoireCD4/CD8 T cell countsCytokine levels (e.g., IFN-γ, IL-2, IL-17)Expression of co-stimulatory molecules (e.g., CD28, CTLA-4, PD-1)

Beyond the preview

Go deeper on T Cell Antigen Recognition via Major Histocompatibility Complex Presentation (TCR-MHC Interaction).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on T Cell Antigen Recognition via Major Histocompatibility Complex Presentation (TCR-MHC Interaction).

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call